The only curative treatment for gastric cancer is surgery. For reasons that are unclear, and likely multi-factorial, survival following gastric cancer surgery in North America is markedly worse than the results reported in Asia and Europe.
The overall objective of this study is to improve surgical care by examining the components of optimal staging and surgical treatment of patients with gastric cancer, and using this information to determine areas in which care can be improved and create algorithms which can be used prospectively by physicians who care for such patients.
